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Abstract
The antimicrobial activity of linear, cationic a-helical peptides from cattle (BMAP28), sheep (SMAP28 and SMAP29), and
pigs (PMAP23) were assessed to determine if activity was selective for Pasteurella multocida from a particular animal species or
broad-spectrum against all P. multocida tested. The antimicrobial activities of synthetic peptides were determined for P.
multocida isolated from cattle (10 isolates), sheep (10 isolates), and pigs (10 isolates) in a broth microdilution assay. All thirty
isolates of P. multocida were susceptible to BMAP28 (MICs and MBCs, 1.0–1.9 mM); SMAP28 and SMAP29 (MICs and
MBCs, 0.2–0.7 mM); and PMAP23 (MICs and MBCs, 4.3 to 6.8 mM). Overall, the results of this study suggest that
synthesized cathelicidins from cattle, sheep, and pigs had broad-spectrum antimicrobial activity against all P. multocida.
# 2006 Elsevier B.V. All rights reserved.
Keywords: Antimicrobial peptides; Innate defense; Cathelicidins; Pasteurella multocida; Cattle; Sheep; Pigs
1. Introduction
Pasteurella multocida is a Gram-negative, faculta-
tive anaerobic, coccobacillus. It occurs as a commen-
sal in the nasopharynx of apparently healthy animals.
It can also be a primary or secondary pathogen in
disease processes of domestic and feral mammals and
birds (Rimler and Rhoades, 1989). As a commensal, P.
multocida can become host-adapted and isolates from
different animal species display unique somatic
serotypes (Blackburn et al., 1975; Rimler et al.,
1984); physiologic characteristics and biotypes (Hed-
dleston, 1976); and capsular morphologies and
capsular types (Rimler and Rhoades, 1989). Under
some circumstances, interspecies transmission of P.
multocida is thought to occur (Davies et al., 2004).
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On oronasal mucosal surfaces of mammals, P.
multocida can induce low grade chronic infections
resulting in mucosal inflammation associated with
neutrophil infiltrates. For example, gnotobiotic pigs
infected intranasally by a toxigenic strain of P.
multocida type D became colonized (Ackermann
et al., 1991). Tonsillar crypt epithelium became
thickened and the tonsil lumen contained intraepithe-
lial leukocytes, neutrophils, and macrophages. At 14
days post-infection, lumens contained mucus, des-
quaminated cells, degranulated neutrophils, and
debris. Occasionally, these organisms reach the lower
respiratory tract in animals and induce pneumonia
(Brockmeier et al., 2001; Brogden et al., 1998; Purdy
et al., 1997).
Almost nothing is known about the host innate
immune factors produced on oronasalmucosal surfaces
that discourage carriage of P. multocida or the bacterial
factors that allow them to resist elimination by host
factors. Likely, the chronic inflammatory response
containing neutrophils and their granular contents play
a role. Neutrophil granular contents contain antimi-
crobial proteins andpeptides, including bovinemyeloid
antimicrobial peptides (BMAP), sheep myeloid anti-
microbial peptides (SMAP), and porcine myeloid
antimicrobial peptides (PMAP) (Gennaro et al.,
1998) and may control P. multocida colonized in the
nasopharynx of the respective host species. The
Pasteurellae culture collection at the National Animal
DiseaseCenter inAmes, IA,USAallowedus the unique
opportunity to assess whether synthesized BMAP28,
SMAP28, SMAP29, and PMAP23 had selective
activity against P. multocida isolated from cattle,
sheep, and pigs, respectively or broad-spectrum of
activity against all P. multocida. In this study, we
assessed the antimicrobial activities of these peptides
forP.multocida isolated fromcattle, sheep, andpigs in a
broth microdilution assay.
2. Materials and methods
2.1. Organisms
Isolates of P. multocida from natural cases of
pasteurellosis in cattle are generally capsular type A
(Davies et al., 2004), isolates from sheep are capsular
types A, D, and F (Davies et al., 2003b), and isolates
from pigs are capsular types A and D (Davies et al.,
2003a). Cattle isolates are somatic serotypes 3; 3,4;
3,12; and 3,4,12; sheep isolates are somatic serotypes
3 and 3,4; and pig isolates are somatic serotypes 3; 4;
and 4,12 (Blackburn et al., 1975). In this study we
selected 30 isolates from the P. multocida culture
collection at the USDA, ARS, National Animal
Disease Center, Ames, IA, USA that were as
representative as possible of these capsular and
somatic serotypes (Table 1); 10 isolates were from
cattle, 10 from sheep, and 10 from pigs. Escherichia
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Table 1
Origin and characteristics of Pasteurella multocida from cattle,
sheep, and pigs
Culture Origin Species Serotype Site of isolation
P-5294 Texas Cattle A:3a Not knownb
P-5024 Idaho Cattle A:3 Lung
P-4922 Wisconsin Cattle A:3 Not known
P-5219 Texas Cattle A:3,4 Not known
P-4691 Virginia Cattle A:3,4 Not known
P-4664 Iowa Cattle A:3,4 Not known
P-5032 Idaho Cattle A:3,12 Nose
P-5238 Wisconsin Cattle A:3,4,12 Not known
P-5368 Idaho Cattle A:12 Not known
P-5649 California Cattle F:3,4 Not known
P-5380 Idaho Sheep A:– Not known
P-2295 Texas Sheep A:3 Lung
P-2294 Texas Sheep A:3 Lung
P-5082 Washington Sheep A:3,4 Not known
P-2299 Texas Sheep A:3,12 Lung
P-5039 Iowa Sheep D:3 Not known
P-1028 Maryland Sheep D:– Not known
P-5183 Washington Sheep F:– Not known
P-5370 Idaho Sheep A:6,12 Not known
P-1773 Pennsylvania Sheep A–:– Not known
P-5522 Canada Pigs A:3 Not known
P-4289 Arkansas Pigs A:3,12 Not known
P-5240 Wisconsin Pigs A:– Not known
P-1293 Iowa Pigs D:3 Not known
P-2279 Missouri Pigs D:3 Not known
P-4290 Arkansas Pigs D:3,12 Not known
P-5715c Canada Pigs D:12 Not Known
P-4986 Iowa Pigs D:12 Not known
P-4275c Arkansas Pigs D:12 Nose
P-1683c Iowa Pigs –:– Not Known
a Designated as capsular:somatic serotype. A dash (–) means that
neither the capsular or somatic serotype, or both, were not known.
b This information was not available. It was not listed in the
official records received from the diagnostic laboratory at the time of
request for capsular and somatic serotyping.
c Porcine strains P-5715, P-4275, and P-1683 were toxigenic and
produced a potent, intracellular, mitogenic toxin known as P.
multocida toxin.
coli ATCC 12795 was used as a susceptible control
organism. P. multocida cultures in this collection have
been maintained in a lyophilized state since their
initial isolation to reduce any phenotypic changes that
might occur as a result of repeated subculture. For this
study, lyophilized cultures were reconstituted with
tryptose broth, plated on dextrose starch agar, and
incubated overnight at 37 8C. Single colonies were
picked and transferred to Mueller Hinton broth
(MHB). After incubation for 24 h at 37 8C, the
cultures were adjusted to an optical density of 0.108 at
600 nm in the spectrophotometer and diluted 103-
fold to contain 1.0  105 CFU ml1.
2.2. Antimicrobial assay
A broth microdilution assay was used (Brogden
et al., 2001; Turner et al., 1998; Wu and Hancock,
1999). Briefly, cathelicidins (Table 2) were synthe-
sized as previously described (Brogden et al., 2001;
Travis et al., 2000) and diluted in 140 mM NaCl
(0.1–25.0 mM) in microtiter plates (Immulon 1
plates, ISC Bioexpress, Kaysville, Utah, USA).
NaCl (140 mM) without peptide was added to
control wells. MHB containing 1.0  105 CFU ml1
1 of P. multocida was added to wells containing
peptides and 140 mM NaCl (positive growth control
wells) and sterile MHB was added to wells
containing 140 mM NaCl (negative growth control
wells). After 24 and 48 h at 37 8C, the optical density
of bacterial growth was determined (600 nm,
Spectromax Microplate Reader, Molecular Devices
Corp., Sunnyvale, CA, USA). The minimal inhibi-
tory concentration (MIC) was defined as the lowest
concentration of peptide that reduced the optical
density of microbial growth by more than 50% of the
positive growth control. Diluent from the preceding
three wells with no optical density of microbial
growth were then spotted onto trypticase soy agar
with 5% defibrinated sheep blood (blood agar). The
minimal bactericidal concentration (MBC) was
defined as the lowest concentration of peptide that
reduced viable growth when 50 ml of the well
contents were plated on blood agar and incubated at
37 8C for 24 h.
3. Results
BMAP28, SMAP28, SMAP29, and PMAP23
were all active against the control strain of E. coli
and MICs and MBCs ranged from 0.1 to 0.4 mM
(Table 3). All thirty isolates of P. multocida were
susceptible to BMAP28 (MICs and MBCs, 3.0–6.0
mg ml1), SMAP28 (MICs and MBCs, 0.3–0.4 mM),
and SMAP29 (MICs and MBCs, 0.2–0.7 mM). All
thirty isolates of P. multocida were susceptible to
PMAP23 (MICs and MBCs, 4.3 to >6.8 mM) but
MICs were approximately 20–40 times higher. Little
variability was seen among the MIC and MBC
values of SMAP28 and SMAP29 for all thirty
isolates of P. multocida. A larger variability was seen
among the MIC and MBC values of BMAP28 and
PMAP23.
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Table 2
Amino acid sequences of 4 cathelicidins from cattle, sheep, and pigs
Animal/Cathelicidin Sequence Reference
Cattle
BMAP28 GGLRSLGRKILRAWKKYGPIIVPIIRIG Skerlavaj et al. (1996)
Sheep
SMAP28a RGLRRLGRKIAHGVKKYGPTVLRIIRIA-NH2
SMAP29 RGLRRLGRKIAHGVKKYGPTVLRIIRIAG Bagella et al. (1995), Brogden et al.
(2001), Mahoney et al. (1995), Skerlavaj et al.
(1999) and Travis et al. (2000)
Pigs
PMAP23 RIIDLLWRVRRPQKPKFVTVWVR Storici et al. (1994), Tossi et al. (1995)
and Zanetti et al. (1994)
a SAMP29 (SC5-1) was the peptide originally deduced from the nucleotide sequence (Mahoney et al., 1995). SMAP28 was the actual peptide
isolated from ovine leukocytes (Kalfa et al., 2001). The C-terminal glycine appears to be post-translationally modified into a –NH2 group.
4. Discussion
P. multocida is a commensal organism in the
oronasal passages of cattle, sheep, and pigs. It can be
isolated in lower numbers from the mucosal surfaces
of apparently healthy animals and in higher concen-
trations from nasal secretions and pulmonary tissues
of animals with polymicrobial upper respiratory
disease and pneumonia (Brogden, 2002). In this
study, we determined the effect to which P. multocida
was susceptible to myeloid antimicrobial peptides and
whether antimicrobial activity was host-species
specific or broad-spectrum. In the context of host–
parasite interactions, it is tempting to speculate that
the host contains commensal (host-adapted) micro-
organisms that are more resistant to innate antimi-
crobial peptides than similar transient organisms
acquired from other animal species. Such an
observation can explain the carriage state or mucosal
inflammatory response seen in animals chronically
colonized with P. multocida. To the contrary, P.
multocida isolates from cattle, sheep, and pigs were all
susceptible to the four cathelicidins from the same
species.
BMAP28, SMAP28, SMAP29, and PMAP23 are
potent antimicrobial peptides (Brogden et al., 2003).
BMAP28 has aMIC of 0.2–8.0 mM for Gram-negative
and Gram-positive bacteria (Benincasa et al., 2003;
Gennaro and Zanetti, 2000; Skerlavaj et al., 1996); 0.1
to >10.2 mM for fungi; and 31.9 mM for protozoan
parasites like Cryptosporidium parvum (Giacometti
et al., 2003). Spirochaetes are susceptible but at much
higher levels of peptide (Sambri et al., 2002).
SMAP28 and SMAP29 have MICs of 0.04–
16.0 mM for Gram-negative bacteria (Anderson
et al., 2004; Gennaro and Zanetti, 2000; Kalfa
et al., 2001; Skerlavaj et al., 1999); 0.08–1.0 mM
for Gram-positive bacteria (Anderson et al., 2004;
Gennaro and Zanetti, 2000; Skerlavaj et al., 1999); 0.3
to >32.0 mM for fungi (Anderson et al., 2004;
Gennaro and Zanetti, 2000; Skerlavaj et al., 1999);
and 3.1–30.7 mM for C. parvum (Giacometti et al.,
2003). Again, spirochaetes are susceptible but at much
higher levels of peptide (Sambri et al., 2002).
Congeners of SMAP29 are also antimicrobial against
bacteria (Kalfa et al., 2001) and fungi (Lee et al.,
2002a). PMAP23 has a MIC of 2–16 mM for Gram-
negative and Gram-positive bacteria (Storici et al.,
1994; Zanetti et al., 1994); 2.5–20.0 mM for fungi
(Lee et al., 2001; Lee et al., 2002b); and 25 mM for
nematodes like Caenorhabditis elegans (Park et al.,
2004). It is either an a-helical antimicrobial peptide
(Lee et al., 2002b) or an antiparallel b-sheet peptide
connected by a loop at the center (Zhang et al., 2000).
Overall, the results of this study suggest that
BMAP28, SMAP28, SMAP29, and PMAP23 are
potent antimicrobial peptides that do not have host-
specific antimicrobial activities. Rather these peptides
appeared to have broad-spectrum antimicrobial
activities against P. multocida isolates from cattle,
sheep, and pigs. However, we used an in vitro, broth-
based assay, and we remain cautious that in vivo there
may be host-specific antimicrobial activities. This
may occur with peptides expressed by their own host
in situ as well as when tested against a microorganism
expressing whatever is appropriate for a given
microenvironment and growing perhaps in a non-
planktonic form.
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Table 3
Antimicrobial activities of SMAP28, SMAP29, PMAP23, and BMAP28 for P. multocida from cattle, sheep, and pigsa
E. coli ATCC 12795 Ten strains of P. multocida
from cattle
Ten strains of P. multocida
from sheep
Ten strains of P. multocida
from pigs
MICb MBCb MIC MBC MIC MBC MIC MBC
BMAP28 0.2  0.0c 0.2  0.0 1.0  0.6d 1.4  0.6 1.0  0.2 1.9  0.2 1.0  0.2 1.8  0.3
SMAP28 0.1  0.0 0.1  0.0 0.3  0.0 0.3  0.1 0.2  0.0 0.4  0.0 0.3  0.0 0.4  0.0
SMAP29 0.1  0.0 0.1  0.0 0.2  0.0 0.6  0.2 0.2  0.1 0.4  0.1 0.2  0.0 0.7  0.3
PMAP23 0.4  0.0 0.4  0.0 6.8 6.8 4.3  1.2 5.6  1.2 >6.8 >6.8
a The susceptibilities of other veterinary pathogens to some of these peptides were much more variable (Kalfa et al., 2001).
b The minimal inhibitory concentration (MIC) and the minimal bactericidal concentration (MBC) of the peptide.
c mM mean + S.E. of three replications (N = 3) for E. coli MIC and MBC.
d mM mean + S.E. of three replications of 10 strains (N = 30) for P. multocida MIC and MBC.
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